The engineered vector SIRPα-Fc-VV replicated successfully in tumour cells, induced the killing of tumour cells in vitro by M1 and M2 macrophages after the addition of conditioned infected cell media to co-cultures, and recruited macrophages and monocytes to tumours in vivo. This evidence concerns the gene SIRPA and neoplasm.